Kepler Capital Markets set a €67.00 ($77.91) price target on Symrise (FRA:SY1) in a research note issued to investors on Thursday morning. The firm currently has a sell rating on the stock.

A number of other research analysts also recently weighed in on SY1. Hauck & Aufhaeuser set a €75.00 ($87.21) price target on shares of Symrise and gave the company a neutral rating in a report on Friday, August 31st. Goldman Sachs Group set a €58.20 ($67.67) price target on shares of Symrise and gave the company a sell rating in a report on Monday, September 3rd. Morgan Stanley set a €75.00 ($87.21) price target on shares of Symrise and gave the company a neutral rating in a report on Wednesday, August 29th. UBS Group set a €73.00 ($84.88) price target on shares of Symrise and gave the company a neutral rating in a report on Tuesday, August 14th. Finally, BNP Paribas set a €90.00 ($104.65) price target on shares of Symrise and gave the company a buy rating in a report on Tuesday, October 2nd. Three research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and five have given a buy rating to the company’s stock. The company has a consensus rating of Hold and an average target price of €74.46 ($86.58).

SY1 stock opened at €71.02 ($82.58) on Thursday. Symrise has a 12-month low of €56.96 ($66.23) and a 12-month high of €73.48 ($85.44).

Symrise Company Profile

Symrise AG develops, produces, and sells fragrances, flavorings, and cosmetic ingredients. It operates through three segments: Scent & Care, Flavor, and Nutrition. The Scent & Care segment develops, produces, and sells fragrance ingredients and compositions, cosmetic ingredients, and mint flours, as well as specific application processes for such substances.

See Also: Should You Consider an Index Fund?

Analyst Recommendations for Symrise (FRA:SY1)

Receive News & Ratings for Symrise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Symrise and related companies with MarketBeat.com's FREE daily email newsletter.